Klotho Neurosciences (NASDAQ:KLTO) Stock Price Down 1.8% – What’s Next?

Klotho Neurosciences, Inc. (NASDAQ:KLTO) shares fell 1.8% on Thursday . The company traded as low as $0.27 and last traded at $0.28. 12,690 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 824,509 shares. The stock had previously closed at $0.28.

Klotho Neurosciences Stock Performance

The stock has a fifty day moving average price of $0.36.

Institutional Investors Weigh In On Klotho Neurosciences

An institutional investor recently raised its position in Klotho Neurosciences stock. Geode Capital Management LLC grew its position in shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) by 122.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 140,606 shares of the company’s stock after buying an additional 77,372 shares during the quarter. Geode Capital Management LLC owned 0.52% of Klotho Neurosciences worth $68,000 as of its most recent filing with the Securities & Exchange Commission. 20.07% of the stock is currently owned by institutional investors and hedge funds.

Klotho Neurosciences Company Profile

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.